Tag: FDA Approval

• Robotic Surgery: Intuitive Surgical Q2 2023 Report

  

  Intuitive Surgical reports impressive Q2 2023 earnings, driven by a 22% YoY increase in procedures using the revolutionary da Vinci system and FDA approval for new procedures. Learn more about this game-changer in the robotic surgery market.

  Read more

  Andy Reimann – StockFit

  July 20, 2023

  Financial Results

  da Vinci Surgical System, FDA Approval, Financial Performance, Healthcare Innovation, Intuitive Surgical, investment, Q2 2023 Earnings, Robotic Surgery